Page 128 - GPD-3-3

Gene & Protein in Disease Hydrogen sulfide ameliorates NAFLD

Gastroenterol. 2022;28(19):2088. 13. Polyzos SA, Kountouras J, Mantzoros CS. Obesity and
nonalcoholic fatty liver disease: From pathophysiology to
doi: 10.3748/wjg.v28.i19.2088
therapeutics. Metabolism. 2019;92:82-97.
2. Guo L, Guo YY, Lib Y, et al. Enhanced acetylation of ATP-
citrate lyase promotes the progression of nonalcoholic fatty doi: 10.1016/j.metabol.2018.11.014
liver disease. J Biol Chem. 2019;294:11805-11816. 14. Zhou L, Li Q, Chen A, et al. KLF15‐activating Twist2
ameliorated hepatic steatosis by inhibiting inflammation
doi: 10.1074/jbc.ra119.008708
and improving mitochondrial dysfunction via NF‐κB‐
3. Kashyap ML, Ganji S, Nakra NK, Kamanna VS. Niacin FGF21 or SREBP1c‐FGF21 pathway. FASEB J. 2019;33(12):
for treatment of nonalcoholic fatty liver disease (NAFLD): 14254-14269.
Novel use for an old drug? J Clin Lipidol. 2019;13:873-879.
doi: 10.1096/fj.201901347rr
doi: 10.1016/j.jacl.2019.10.006 15. Nozaki Y, Kobayashi M, Wakasawa H, et al. Systemic
4. Sheka AC, Adeyi O, Thompson J, et al. Nonalcoholic depletion of WWP1 improves insulin sensitivity and lowers
steatohepatitis: A review. JAMA. 2020;323(12):1175-1183. triglyceride content in the liver of obese mice. FEBS Open
Bio. 2023;13(6):1086-1094.
doi: 10.3390/ijms241914482
doi: 10.1002/2211-5463.13610
5. Shirazi F, Wang J, Wong RJ. Nonalcoholic steatohepatitis
becomes the leading indication for liver transplant 16. Cui X, Yao M, Feng Y, et al. Exogenous hydrogen sulfide
registrants among US adults born between 1945 and 1965. alleviates hepatic endoplasmic reticulum stress via
J Clin Exp Hepatol. 2020;10:30-36. SIRT1/FoxO1/PCSK9 pathway in NAFLD. FASEB J.
2023;37(8):e23027.
doi: 10.1016/j.jceh.2019.06.007
doi: 10.1096/fj.202201705rr
6. Younossi ZM. Non-alcoholic fatty liver disease-a global
public health perspective. J Hepatol. 2019;70:531-544. 17. Zou J, Yuan Z, Chen X, et al. Hydrogen sulfide responsive
nanoplatforms: Novel gas responsive drug delivery
doi: 10.1016/j.jhep.2018.10.033 carriers for biomedical applications. Asian J Pharm Sci.
7. Papatheodoridi AM, Chrysavgis L, Koutsilieris M, et al. The 2023;19:100858.
role of senescence in the development of nonalcoholic fatty doi: 10.1016/j.ajps.2023.100858
liver disease and progression to nonalcoholic steatohepatitis.
Hepatology. 2020;71(1):363-374. 18. Sun HJ, Wu ZY, Nie XW, Wang XY, Bian JS. Implications
of hydrogen sulfide in liver pathophysiology: Mechanistic
doi: 10.1002/hep.30834 insights and therapeutic potential. J Adv Res. 2021;27:127-135.
8. Wu WK, Zhang L, Chan MT. Autophagy, NAFLD and doi: 10.1016/j.jare.2020.05.010
NAFLD-related HCC. Adv Exp Med Biol. 2018,1061:127-138.
19. Wang Y, Yu R, Wu L, Yang GD. Hydrogen sulfide signaling
doi: 10.1007/978-981-10-8684-7_10 in regulation of cell behaviors. Nitric Oxide. 2020;103:9-19.
9. Roeb E. Diagnostic and therapy of nonalcoholic fatty liver doi: 10.1016/j.niox.2020.07.002
disease: A narrative review. Visc Med. 2022;38(2):126-132.
20. Ge Y, Rong F, Li W, Wang Y. On-demand therapeutic delivery
doi: 10.1159/000519611 of hydrogen sulfide aided by biomolecules. J Control Release.
10. Han CY, Rho HS, Kim A, et al. FXR inhibits endoplasmic 2022;352:586-599.
reticulum stress-induced NLRP3 inflammasome doi: 10.1016/j.jconrel.2022.10.055
in hepatocytes and ameliorates liver injury. Cell
Rep. 2018;24(11):2985. 21. Abdollahi Govar A, Törő G, Szaniszlo P, et al.
3-Mercaptopyruvate sulfurtransferase supports endothelial
doi: 10.1016/j.celrep.2018.07.068 cell angiogenesis and bioenergetics. Br J Pharmacol.
11. Loomba R, Friedman SL, Shulman GI. Mechanisms and 2020;177(4):866-883.
disease consequences of nonalcoholic fatty liver disease. doi: 10.1111/bph.14574
Cell. 2021;184(10):2537-2564.
22. Ahmad A, Druzhyna N, Szabo C. Cystathionine-gamma-
doi: 10.1016/j.cell.2021.04.015 lyase deficient mice are protected against the development
of multiorgan failure and exhibit reduced inflammatory
12. Fang YL, Chen H, Wang CL, Liang L. Pathogenesis of non-
alcoholic fatty liver disease in children and adolescence: response during burn. Burns. 2017;43(5):1021-1033.
From “two hit theory” to “multiple hit model”. World J doi: 10.1016/j.burns.2017.02.011
Gastroenterol. 2018;24(27):2974-2983.
23. Ali A, Zhang Y, Fu M, et al. Cystathionine gamma-lyase/
doi: 10.3748/wjg.v24.i27.2974 H2S system suppresses hepatic acetyl-CoA accumulation

Volume 3 Issue 3 (2024) 10 doi: 10.36922/gpd.3409